GB2405350A — A nasal delivery device operated by exhalation into a mouthpiece
Assigned to Optinose AS · Expires 2005-03-02 · 21y expired
What this patent protects
A delivery device has an outlet member <B>19</B> through which substance, as an aerosol or vapour is delivered in an entraining gas flow, and a substance supply unit <B>15</B>. The substance supply unit <B>15</B> comprises a flow channel <B&…
USPTO Abstract
A delivery device has an outlet member <B>19</B> through which substance, as an aerosol or vapour is delivered in an entraining gas flow, and a substance supply unit <B>15</B>. The substance supply unit <B>15</B> comprises a flow channel <B>21</B> fluidly connected to the outlet member <B>19</B> and a substance supporting element <B>27</B> for supporting substance, at least a surface of which is disposed in the flow channel <B>21.</B> The substance is entrained by the gas flow flowing over or through the substance supporting element <B>27.</B> The device may also have a mouthpiece <B>17</B> which is fluidly connected to the flow channel <B>21,</B> whereby exhalation into the mouthpiece <B>17</B> generates an entraining gas flow. The substance supporting element <B>27</B> may comprise a porous capillary element loadable with substance and the flow channel <B>21</B> may comprise an upstream flow section and a downstream flow section with a flow resistor <B>31</B> fluidly connecting the upstream and downstream channels. The outlet may comprise a nosepiece <B>19</B> for fitting into a nostril. Also disclosed is a delivery device comprising an outlet member, a substance supply unit wherein the substance supply unit comprises a flow channel which is fluidly connected to the outlet member and defines a receiving chamber; a cartridge containing substance to be entrained which is openable to release a contained substance; a method of delivering substance by providing a substance supporting element in a flow channel, delivering an entraining gas flow through the flow channel to entrain substance from the substance supporting element.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.